IL5 and Alzheimer disease: Th2 cell-mediated changes in interleukin-4 (IL-4), IL-5, and IL-13 expressions have been reported in the acute phase of AD, whereas in the chromic stages, Th1 cell-mediated AD lesions were found6,.7